PEPTIDE CORPUS

Body and drug basics

CD38

Last updated

An enzyme that breaks down NAD+. CD38 activity increases with age and is considered a key driver of age-related NAD+ decline.

Why it matters here

It is the mechanism most often named for why NAD+ falls over a lifetime. No compound in this corpus is recorded as acting on CD38, so this is a term you meet in the reading rather than one you will find on a record.

What it is not

An enzyme, not a compound anyone takes. There is no CD38 record here because CD38 is the target being described, not the intervention.

Also called

Compounds carrying this term

None on file yet. This term is in the controlled vocabulary but no compound record currently uses it — which is a statement about our coverage, not about the term.

See also